07Oct
05Oct
Why Corbus Pharmaceuticals Holdings Inc Shares Skyrocketed Today
Corbus Pharmaceuticals (NASDAQ: CRBP) is up 29% at 1:18 p.m. EDT after an analyst at Cantor Fitzgerald initiated coverage of the biotech with a buy rating. There's plenty to learn about Corbus Pharmaceuticals. The biotech only has one drug, resunab, but it's testing the anti-inflammatory drug in multiple indications: cystic fibrosis, systemic sclerosis, dermatomyositis, and lupus. Read more >>
22Sep
Skyline Medical and GLG Pharma Enter into Partnership to Develop Diagnostic Tests for Skyline’s STREAMWAY System
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a partnership and exclusive reseller agreement with GLG Pharma, LLC (“GLG”). Read more >>
22Sep
AOBiome Announces First-of-its Kind Trial of Live Topical Bacterial Treatment for Acne
Leading skin microbiome company AOBiome announced today the launch of its Phase 2B trial using its first-in-class live bacteria to treat acne. Phase 2B marks the advancement from the company's successful Phase 1B/2A dose-ranging safety study, which resulted in no serious adverse events and no difference in adverse events between treatment and vehicle groups. Read more >>
21Sep
Professional athletic trainers adopt sam® Sport to accelerate injury recovery and reduce opioid use for pain management
ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams. Read more >>
21Sep
Congratulations to Boston Harbor Angels on Being Named “BUILD Friend of the Year” as Part of the 5-Year Anniversary BUILDFest Gala
BUILD will award Mic Williams and Boston Harbor Angels the “BUILD Friend of the Year Award” as part of their 5-Year Anniversary BUILDFest Gala, which will be held on Wednesday October 19th from 5:30-9:30 pm at the Boston Convention Center. BUILD and Boston Harbor Angels have partnered and are very happy to be able to bring more resources to help at-risk youth. Read more >>
16Sep
Premama® Achieves 700% Record Growth, Continuing to Fuel the Emerging Maternity Wellness Category
Premama®, the first nationwide line of natural powdered drink mixes and soft chews to support complete maternity wellness from preconception through pregnancy and beyond, today announced a record retail expansion, experiencing rapid growth from 1,100 to 7,700 retail distribution points since April 2015 and a significant 360% growth in sales from August 2015 to August 2016. Spearheading maternity wellness as a retail category, Premama has pioneered industry awareness and consumer demand with products for the entire maternity journey. Read more...
14Sep
Vice Provost Brush Receives Dedication To Entrepreneurship Award
The Academy of Management Entrepreneurship Division has awarded the Dedication To Entrepreneurship Award to Babson Vice Provost of Global Entrepreneurial Leadership Candy Brush. Read more >>
14Sep
Siamab Therapeutics Presents Promising Preclinical Data at 2016 AACR Ovarian Cancer Research Symposium
Siamab Therapeutics, Inc., a biotechnology company developing novel cancer immunotherapies, today announced new pre-clinical data that showed its novel ST1 antibody drug conjugates (ADCs) target chemoresistant ovarian cancer cells and demonstrate strong efficacy in ovarian cancer models. These data were presented at the American Association for Cancer Research (AACR)’s 11th Biennial Ovarian Cancer Research Symposium 2016 in Seattle, Wash., on Monday, Sept. 12, 2016. Read more >>
07Sep